What does the Primary Care Dermatology Society say about the treatment of plaque psoriasis in primary care?
The Primary Care Dermatology Society (PCDS) has created a treatment pathway to support GPs and GPSIs in dermatology. It states:2,3
” A combination product is often considered a first line option for chronic plaque psoriasis on the body as an effective and cosmetically acceptable therapy. “
” Many GPs and GPSIs use calcipotriol and betamethasone combination products first line… in chronic plaque psoriasis…* “
* This statement differs from the NICE guidelines, which state: “offer a potent corticosteroid applied once daily plus vitamin D or a vitamin D analogue applied once daily (applied separately, one in the morning and the other in the evening) for up to 4 weeks as initial treatment for adults with trunk or limb psoriasis.3 SIGN guidelines list short-term intermittent use of a potent topical corticosteroid or a combined potent corticosteroid plus calcipotriol ointment for rapid improvement in plaque psoriasis.5
What do primary care experts in dermatology say about the guidelines for plaque psoriasis?
Enstilar® is a combination product containing calcipotriol and betamethasone dipropionate in a foam spray formulation
As a combination product, Enstilar® tackles both aspects of psoriasis.1